Jeffrey S. Farrow
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | $541,667 | $2,677,617 |
| 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | $520,833 | $3,232,926 |
| 2023 | Tarsus Pharmaceuticals, Inc. (TARS) | Chief Financial Officer and Chief Strategy Officer | $343,751 | $3,991,830 |
Recent activity
Earnings-call appearances and filed executive appointments or departures, newest first.